Your pharma operations team runs validation on a legacy manufacturing system that updates every few months. The bots break. Your RPA team spends weeks rebuilding selectors and flows. Meanwhile, the SOP for that step is already written in plain English, but nobody can turn it into a working script. You end up with a backlog of tasks that require human judgment, and your automation efforts look like a treadmill rather than a foundation.
Why RPA breaks here
In pharma, you cannot afford broken processes. Validation demands repeatability and auditability, yet traditional RPA relies on brittle selectors and object IDs. When a vendor changes a field label, moves a button, or reorganizes a page, the bot fails. A recent industry study found that RPA maintenance accounts for 30 to 45 percent of total automation costs. Developers spend more time patching bots than building new ones. In regulated environments, each change requires re-validation documentation, which stretches timelines and risks compliance gaps.
What changes with computer use agents
- Survives UI changes: agents see the screen and infer controls from context, so new layouts do not require selector updates.
- No brittle selectors: there are no xpaths or object IDs to maintain. The agent works with what it can see and click.
- Recovers from exceptions: when a modal appears or a field is disabled, the agent reads the state, decides what to do, and continues instead of halting.
- Follows the SOP as written: plain language instructions become executable logic, so you do not need a separate flowchart bot.
- Works on legacy and Citrix: agents can interact with virtual desktops and older applications where modern RPA struggles.
Computer use agents let you keep the process but upgrade the machine.
How to move without the risk
You do not need to rip out all RPA at once. Start with one high-pain process that is SOP-based, has frequent UI changes, or lives on legacy systems. Run a pilot with a computer use agent. Compare the time to implement, the time to maintain, and the number of exceptions. If the agent works as expected, expand the scope. Keep the stable, high-volume backend tasks on RPA where they excel. Use agents for the long tail, exception-heavy workflows, and processes governed by written procedures. This hybrid approach lets you modernize incrementally while staying compliant.
Pharma and life sciences teams can move from brittle bots and unreadable SOPs to validated workflows that adapt automatically. To see how computer use agents can support your critical processes, book a demo with the Coasty team at https://cal.com/coasty/15min .
Want to see this in action?
View Case Studies